Search results
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 2 months agoMerck MRK reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks...
Merck (MRK) Q3 Earnings Top Estimates, COVID Drug Boosts Sales
Zacks via Yahoo Finance· 8 months agoMerck MRK reported adjusted earnings of $2.13 per share for third-quarter 2023, beating the Zacks...
Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
Reuters via Yahoo News· 2 years agoU.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy...
Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints
Zacks via Yahoo Finance· 1 year agoMerck MRK reported fourth-quarter 2022 adjusted earnings of $1.62 per share, which beat the Zacks...
Merck (MRK) Beats on Q3 Earnings & Revenues, Ups 2022 View
Zacks via Yahoo Finance· 2 years agoMerck & Co., Inc. MRK reported third-quarter 2022 adjusted earnings of $1.85 per share, beating the...
Why Is Merck (MRK) Up 4.3% Since Last Earnings Report?
Zacks via Yahoo Finance· 9 months agoIt has been about a month since the last earnings report for Merck (MRK). Shares have added about...
Merck (MRK) Q4 Earnings Beat, Sales Miss, Upbeat '24 View
Zacks via Yahoo Finance· 4 months agoMerck MRK reported adjusted earnings of 3 cents per share in fourth-quarter 2023, wider than the...
Mirati's (MRTX) Q4 Loss Narrows, Krazati Records First Sales
Zacks via Yahoo Finance· 1 year agoMirati Therapeutics MRTX reported a loss of $3.51 per share for fourth-quarter 2022, narrower than...
Personalized cancer vaccine results are a 'home run': Moderna CEO
Yahoo Finance via AOL· 2 years agoPreliminary results from a personalized cancer vaccine jointly studied by Moderna (MRNA) and Merck...
A Bull Market Is Here: 2 Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 5 months agoWith the S&P 500 index recently hitting a new all-time high, we can officially declare that we are...